• 1
    Rabkin JG, Ferrando S, Jacobsberg L, Fishman B. Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Compr Psychiatry. 1997;38:146 54.
  • 2
    Stober D, Schwartz J, McDaniel J, Abrams R. Depression and HIV disease: prevalence, correlates, and treatment. Psychiatr Ann. 1997;27:372 7.
  • 3
    Lesserman J, Petitto J, Perkinds D, et al. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. Arch Gen Psychiatry. 1997; 54:279 85.
  • 4
    Zorilla E, McKay J, Luborsky L, Schmidt K. Relation of stressors and depressive symptoms to clinical progression of viral illness. Am J Psychiatry. 1996;153:626 35.
  • 5
    Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: the effects of stress, depressive symptoms and social support. Psychosom Med. 1999;61:397 406.
  • 6
    Holmes W, Bix B, Meritz M, Turner J, Hutelmeyer C. Human immunodeficiency virus (HIV) infection and quality of life: the potential impact of axis I psychiatric disorders in a sample of 95 HIV seropositive men. Psychosom Med. 1997;59:187 92.
  • 7
    Patterson T, Shaw W, Semple S, et al. Relationship of psychosocial factors to HIV disease progression. Ann Behav Med. 1996;18:30 9.
  • 8
    Mayne T, Vittinghoff E, Chesney M, et al. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med. 1996;156:2233 8.
  • 9
    Markowitz J, Rabkin J, Perry SW. Treating depression in HIV-positive patients. AIDS. 1994;8:403 12.
  • 10
    Rabkin J, Wagner G, Rabkin R. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial. J Clin Psychiatry. 1994;55:433 9.
  • 11
    Rabkin J, Rabkin R, Wagner G. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness. J Clin Psychiatry. 1994;55:92 7.
  • 12
    Hintz S, Kuck J, Peterkin J, Volk D, Zisook S. Depression in the context of human immunodeficiency virus infection: implications for treatment. J Clin Psychiatry. 1990;51:497 501.
  • 13
    Fernandez F & Levy J. Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection. Psychiatr Med. 1991;9:377 94.
  • 14
    Elliott A, Uldall K, Bergam K, Russo J, Claypoole K, Roy-Byrne P. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Am J Psychiatry. 1998;155:367 72.
  • 15
    Vali F & Walkup J. Combined medical and psychological symptoms: impact on disability and health care utilization of patients with arthritis. Med Care. 1998;36:1073 84.
  • 16
    Unutzer J, Patrick D, Simon G, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. JAMA. 1997;277(20):1618 23.
  • 17
    Manning W Jr & Wells K. The effects of psychological distress and psychological well-being on use of medical services. Med Care. 1992;30:541 53.
  • 18
    Von Korff M, Ormel J, Katon W, Lin E. Disability and depression among high utilizers of health care: a longitudinal analysis. Arch Gen Psychiatry. 1992;49:91 100.
  • 19
    Frank RG, Busch SH, Berndt ER. Measuring prices and quantities of treatment for depression. Am Econ Rev. 1998;88:106 11.
  • 20
    Katzelnick D, Kobak K, Greist J, Jefferson J, Henk H. Effect of primary care treatment of depression on service use by patients with high medical expenditures. Psychiatr Serv. 1997;48:59 64.
  • 21
    McCombs JS, Nichol MB, Stimmel GL, Sclar DA, Beasley CM, Gross LS. The cost of antidepressant drug therapy failure: a study of antidepressant drug use in a Medicaid population. J Clin Psychiatry. 1990;51 (suppl 6):60 9.
  • 22
    Thompson D, Buesching D, Gregor KJ, Oster G. Patterns of antidepressant use and their relation to costs of care. Am J Manag Care. 1996;2:1239 46.
  • 23
    Olfson M, Sing M, Schlesinger H. Mental health/medical care cost offsets: opportunities for managed care. Health Aff. 1999;18:79 90.
  • 24
    Katon W, Von Korff M, Lin E, et al. A randomized trial of psychiatric consultation with distressed high utilizers. Gen Hosp Psychiatry. 1992;14:86 98.
  • 25
    Melfi CA, Croghan TW, Hanna MP. Access to treatment for depression in a Medicaid population. J Health Care Poor Underserved. 1999;10:201 15.
  • 26
    Conviser R, Gamliel S, Honberg L. Health-based payment for HIV/AIDS in Medicaid managed care programs. Health Care Financ Rev. 1998;19:63 82.
  • 27
    Crystal S, Sambamoorthi U, Merzel C. The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res. 1995;30:593 614.
  • 28
    Markson LE, McKee L, Mauskopf J, Houchens R, Fanning TR, Turner BJ. Patterns of Medicaid expenditures after AIDS diagnosis. Health Care Financ Rev. 1994;15:43 59.
  • 29
    Halvorsen R & Palmquist R. The interpretation of dummy variables in semilogarithmic equations. Am Econ Rev. 1980;70:474 5.
  • 30
    Kessler R, McGonagle K, Swartz M, Blazer D, Nelson C. Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993;29:85 96.
  • 31
    Miller N, Klamen D, Hoffmann N, Flaherty J. Prevalence of depression and alcohol and other drug deprendence in addictions treatment populations. J Psychoactive Drugs. 1996;28:111 24.
  • 32
    Ziedonis D, Rayford B, Bryant K, Rounsaville B. Psychiatric comorbidity in white and African-American cocaine addicts seeking substance abuse treatment. Hosp Community Psychiatry. 1994; 45:43 9.
  • 33
    Leo R, Sherry C, Jones A. Referral patterns and recognition of depression among African American and Caucasian patients. Gen Hosp Psychiatry. 1998;20:175 82.
  • 34
    Sussman L, Robins L, Earls F. Treatment seeking for depression by black and white Americans. Soc Sci Med. 1987;24:187 96.
  • 35
    Gallo JJ, Marino S, Ford D, Anthony J. Filters on the pathway to mental health care, II: sociodemographic factors. Psychol Med. 1995;25:1149 60.
  • 36
    Padgett DK, Patrick C, Burns B, Schlesinger H. Ethnicity and the use of outpatient mental health services in a national insured population. Am J Public Health. 1994;84:222 6.
  • 37
    Pincus HA, Tanielan TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998;279:526 31.
  • 38
    Wagner GJ, Rabkin JG, Rabkin R. A comparative analysis of standard and alternative antidepressants in the treatment of human immunodeficiency virus patients. Comp Psychiatry. 1996;37:402 8.
  • 39
    Wagner GJ, Rabkin JG, Rabkin R. Dextroamphetamine as a treatment for depression and low energy in AIDS patients: a pilot study. J Psychosom Res. 1997;42:407 11.
  • 40
    Markowitz JC, Klerman GL, Clougherty KF, et al. Individual psychotherapies for depressed HIV-positive patients. Am J Psychiatry. 1995;152:1504 9.
  • 41
    Markowitz JC, Kocsis JH, Fishman B, et al. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry. 1998;55:452 7.
  • 42
    Cazzullo CL, Bessone E, Bertrando P, et al. Treatment of depression in HIV-infected patients. J Psychiatry Neurosci. 1998;23:293 7.
  • 43
    Ferrando SJ, Goldman JD, Charness WE. Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS: improvements in affective and somatic symptoms. Gen Hosp Psychiatry. 1997;19:89 97.
  • 44
    Smith SR & Kirking DM. Access and use of medications in HIV disease. Health Serv Res. 1999;34:123 44.
  • 45
    Sirey JA, Meyers BS, Bruce ML, et al. Predictors of antidepressant prescription and early use among depressed outpatients. Am J Psychiatry. 1999;156:690 6.
  • 46
    Stein M, Piette J, Mor V, et al. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med. 1991;6:35 40.
  • 47
    Rawson N, Malcolm E, D'arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol. 1997;32:191 9.
  • 48
    Kashner T. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care. 1998;36:1324 36.
  • 49
    Walkup J, Boyer C, Kellerman S. Using Medicaid claims for research, clinical decision making, and policy: how reliable can they be? Admin Mental Health. 2000;27:129 39.
  • 50
    Rost K, Smith R, Matthews DB, Guise B. The deliberate misdiagnosis of major depression in primary care. Arch Fam Med. 1994;3:333 7.
  • 51
    Fairfield KM, Libman H, Davis RB, et al. Delays in protease inhibitor use in clinical practice. J Gen Intern Med. 1999;14:395 401.